Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr James Larkin, a postdoctoral researcher from Nicola Sibson’s lab in the CRUK/MRC Oxford Institute for Radiation Biology, has won a silver medal in 2018 STEM for Britain, a Parliamentary poster competition that gives researchers the chance to present their work to policymakers and politicians and discuss their work with local MPs.

STEM for Britain, organised by the Parliamentary and Scientific Committee with support from the Royal Society of Biology, Royal Academy of Engineering, Royal Society of Chemistry and the Institute of Physics, is open to early career researchers engaged in scientific, engineering, technological or medical research.

James, alongside more than 40 bioscientists at the event, presented his research on brain tumour diagnostics, taking one of three medals home from the competition. His research is on developing a technique to diagnose brain tumours as early as possible by profiling the metabolites in urine samples.

Around one in five cancer patients develop secondary tumours, or metastases, which spread to the brain. These are hard to diagnose early using current techniques and late-stage diagnosis limits therapeutic options. James and the team have shown that this novel technique can be used to diagnose and track development of metastases in mice and are now trialling the same methods in patients with brain metastases.

On winning the award, James said, "I had a great time at the STEM for Britain event and met a number of people interested in my research and its applications. To be recognised with an award as well is a fantastic honour and I would like to thank the judges for their confidence in my work.

"In addition, I would like to thank my funders, Cancer Research UK and the Medical Research Council, for supporting this work, as well as my colleagues and collaborators, without whom none of this project would be possible."
Stephen Metcalfe MP, chair of the Parliamentary and Scientific Committee, said: "This annual competition is an important date in the parliamentary calendar because it gives MPs an opportunity to speak to a wide range of the country's best young researchers.

"These early career engineers, mathematicians and scientists are the architects of our future and STEM for Britain is politicians' best opportunity to meet them and understand their work."

Similar stories

Study Publishes New Insights on Goblet Cell Differentiation in Colorectal Cancer

The Oncology Department at the University of Oxford is excited to announce the forthcoming publication in the Proceedings of the National Academy of Sciences (PNAS) of the research paper “Goblet Cell Differentiation Subgroups in Colorectal Cancer.” This groundbreaking study sheds light on the role of goblet cell differentiation in colorectal cancer (CRC) and its impact on cancer progression and prognosis.

Ground-breaking Study reveals previously unknown genetic causes of Colorectal Cancer

A pioneering study, led by UK universities, including the University of Oxford, The Institute of Cancer Research, London, the University of Manchester and the University of Leeds, has provided the most comprehensive analysis to date of the genetic makeup of colorectal cancer (CRC).

Subashan Vadibeler wins 2024 Lasker Essay Contest

Subashan Vadibeler, a recent Oxford Rhodes scholar and Department of Oncology student, is one of five co-winners of the international 2024 Lasker Essay Contest, sponsored by the Lasker Foundation.

Glowing dye helps surgeons eradicate prostate cancer

A glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in real-time, according to a study led by the University of Oxford.

New funding for development of world's first lung cancer vaccine

Oxford and UCL researchers seeking to create the world’s first vaccine to prevent lung cancer in people at high risk of the disease have been granted up to £1.7 million from Cancer Research UK and the CRIS Cancer Foundation.